The course will provide a basic understanding of the technology transfer of analytical methods, quality control standards, packaging components/operations and various pharmaceutical dosage forms from R&D to manufacturing.
Catalent is a world leader in drug delivery solutions with a proven track record of helping customers create better treatments by boosting bioavailability, solubility, and permeability; improving ease and route of administration; and increasing patient compliance. Catalent's unique drug delivery technologies include softgels and Vegicaps® capsules and controlled release technologies such as OptiMeltTM hot melt extrusion, OSDrC® OptiDoseTM optimized dosing, and Zydis® fast-dissolvetablets, to help you get more molecules to market faster and enhance product performance.
Michael Valazza is currently Vice President of Global Business Development specializing in Modified Release Technology and other differentiated oral Pharmaceuticaldosage forms for Catalent Pharma Solutions, a position he has held since 2007. Mr. Valazza has over 30 years of experience in the pharmaceutical industry,having worked previously for Glatt Air Techniques and Schering Pharmaceuticals. Mr. Valazza is a registered pharmacist, a member of a variety of professional organizations including the American Association of Pharmaceutical Scientists and the Controlled Release Society, and has published articles in various scientific journals. He has also made presentations at many conferences on subjects relating to outsourcing,technology transfer and fluid bed processing. Mr. Valazza attended Rutgers University where he received a B.S. in Pharmacy in 1982.
For more information on this course, please click here.
Companies in this article
